Biocon reports two-fold jump in Q4 consolidated net profit

09 May 2025 Evaluate

Biocon has reported results for fourth quarter (Q4) and year ended March 31, 2025.

The company has reported 51.43% rise in its net profit at Rs 21.20 crore for the quarter under review as compared to Rs 14 crore for the same quarter in the previous year. The total income of the company increased by 23.62% at Rs 706.50 crore for Q4FY25 as compared Rs 571.50 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported two-fold jump in its net profit at Rs 459.40 crore for fourth quarter ended March 31, 2025 as compared to Rs 222.90 crore for the same quarter in the previous year. The total income of the company increased by 12.31% at Rs 4,453.90 crore for Q4FY25 as compared Rs 3,965.70 crore for the corresponding quarter previous year. 

For the year ended March 31, 2025, the company has reported over five-fold jump in its net profit at Rs 609.30 crore as compared to Rs 119.30 crore for the previous year. The total income of the company increased by 7.09% at Rs 2,484.90 crore for year under review as compared to Rs 2,320.30 crore for year ended March 31, 2024.

For the year ended March 31, 2025, on the consolidated basis, the company has reported 10.14% rise in its net profit at Rs 1,429.40 crore as compared to Rs 1,297.80 crore for the previous year. The total income of the company increased by 5.43% at Rs 16,469.90 crore for year under review as compared to Rs 15,621.20 crore for year ended March 31, 2024.

Biocon Share Price

392.80 4.55 (1.17%)
05-Dec-2025 15:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1805.00
Dr. Reddys Lab 1276.55
Cipla 1520.55
Zydus Lifesciences 933.10
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×